These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6099685)

  • 1. Alternatives in hepatoprotection: cytoprotection--influences on mono-oxidase system--free radical scavengers (a review).
    Pár A; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):409-23. PubMed ID: 6099685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental models for the study of hepatoprotection.
    Fehér J; Pollák Z; Sréter L; Toncsev H; Cornides A; Gógl A; Vereckei A
    Acta Physiol Hung; 1984; 64(3-4):401-7. PubMed ID: 6532127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system.
    Hunter AL; Holscher MA; Neal RA
    J Pharmacol Exp Ther; 1977 Feb; 200(2):439-48. PubMed ID: 839448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chemical compounds of varying toxicity on the free-radical content and microsomal system of multifunction oxidases in animal liver].
    Shuliakovskaia TS; Saprin AN; Emanuél' NM
    Dokl Akad Nauk SSSR; 1973; 210(1):221-3. PubMed ID: 4351007
    [No Abstract]   [Full Text] [Related]  

  • 5. Biliary excretion of N,N-dimethyl-4-aminoazobenzene (DAB) in the rat. Effects of pretreatment with inducers and inhibitors of the mixed-function oxidase system and with agents that deplete liver glutathione.
    Levine WG; Finkelstein TT
    Drug Metab Dispos; 1978; 6(3):265-72. PubMed ID: 26547
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antioxidants in liver protection].
    Hagymási K; Blázovics A
    Orv Hetil; 2004 Jul; 145(27):1421-5. PubMed ID: 15320484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of free-radical reactions in liver diseases.
    Fehér J; Vereckei A; Lengyel G
    Acta Physiol Hung; 1992; 80(1-4):351-61. PubMed ID: 1345201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide radical as an intermediate in the oxidation of hydroxylamines by mixed function amine oxidase.
    Rauckman EJ; Rosen GM; Kitchell BB
    Mol Pharmacol; 1979 Jan; 15(1):131-7. PubMed ID: 34088
    [No Abstract]   [Full Text] [Related]  

  • 9. The protective role of some antioxidants and scavengers on the free radicals-induced inhibition of the liver iodothyronine 5'-monodeiodinase activity and thiols content.
    Brzezińska-Slebodzińska E; Pietras B
    J Physiol Pharmacol; 1997 Sep; 48(3):451-9. PubMed ID: 9376628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different elimination and effect on mixed function oxidase of 20-methyl-cholanthrene after intragastric and intraperitoneal administration.
    Aitio A
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):701-10. PubMed ID: 4456502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of enzymatic phospholipid peroxidation in the mechanism of endoplasmic reticulum membrane uncoupling in vivo].
    Kagan VE; Kotelevtsev SV; Kozlov IuP
    Dokl Akad Nauk SSSR; 1974; 217(1):213-6. PubMed ID: 4152420
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of free radicals, oxidative stress and antioxidant systems in liver diseases].
    Jakus V; Lopuchova M
    Bratisl Lek Listy; 1999; 100(10):548-59. PubMed ID: 10649852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopharmacologic agents in the amelioration of hepatic injuries.
    Farghali H; Masek K
    Int J Immunopharmacol; 1998; 20(4-5):125-39. PubMed ID: 9730249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver and metabolism of drugs].
    Darnis F
    Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
    [No Abstract]   [Full Text] [Related]  

  • 15. Properties of benzpyrene hydroxylase in the liver, intestinal mucosa and adrenal of untreated and 3-methylcholanthrene-treated rats.
    Zampaglione NG; Mannering GJ
    J Pharmacol Exp Ther; 1973 Jun; 185(3):676-85. PubMed ID: 4712656
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of allopurinol, (+)-cyanidanol-3 and dihydroquinoline-type antioxidants on rat hepatic microsomal cytochrome P-450 and monooxygenases.
    Horváth T; Karge E; Jávor T; Klinger W
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):201-3. PubMed ID: 3583469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver mixed function oxidase activity as an early diagnostic index of toxic exposure].
    Kaskevich LM; Sedokur LK
    Gig Tr Prof Zabol; 1979 Oct; (10):29-32. PubMed ID: 535735
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors affecting the properties of mixed-function oxidases in the liver and small intestine of neonatal rabbits.
    Tredger JM; Chhabra RS
    Drug Metab Dispos; 1980; 8(1):16-22. PubMed ID: 6102025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
    Hennings G
    Arzneimittelforschung; 1979; 29(5):720-4. PubMed ID: 387044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver.
    Tavoloni N; Boyer JL
    J Pharmacol Exp Ther; 1980 Aug; 214(2):269-74. PubMed ID: 7391977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.